JSC
Jackson Square Capital’s Corvus Pharmaceuticals CRVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $255K | Hold |
63,773
| – | – | 0.06% | 136 |
|
|
2025
Q1 | $203K | Hold |
63,773
| – | – | 0.07% | 131 |
|
|
2024
Q4 | $341K | Hold |
63,773
| – | – | 0.08% | 128 |
|
|
2024
Q3 | $337K | Hold |
63,773
| – | – | 0.08% | 116 |
|
|
2024
Q2 | $116K | Hold |
63,773
| – | – | 0.03% | 126 |
|
|
2024
Q1 | $114K | Hold |
63,773
| – | – | 0.03% | 135 |
|
|
2023
Q4 | $112K | Hold |
63,773
| – | – | 0.04% | 116 |
|
|
2023
Q3 | $93.1K | Hold |
63,773
| – | – | 0.04% | 107 |
|
|
2023
Q2 | $146K | Hold |
63,773
| – | – | 0.06% | 111 |
|
|
2023
Q1 | $58K | Hold |
63,773
| – | – | 0.03% | 106 |
|
|
2022
Q4 | $54.2K | Hold |
63,773
| – | – | 0.03% | 118 |
|
|
2022
Q3 | $52K | Hold |
63,773
| – | – | 0.03% | 120 |
|
|
2022
Q2 | $63K | Hold |
63,773
| – | – | 0.03% | 137 |
|
|
2022
Q1 | $105K | Buy |
+63,773
| New | +$105K | 0.03% | 177 |
|